首站-论文投稿智能助手
典型文献
Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases
文献摘要:
Ras homolog(Rho)-associated kinases(ROCKs)belong to the serine-threonine kinase family,which plays a pivotal role in regulating the damage,survival,axon guidance,and regeneration of neurons.ROCKs are also involved in the biological effects of immune cells and glial cells,as well as the development of neurodegenerative disorders such as Alzheimer's disease,Parkinson's disease,and multiple sclerosis.Previous studies by us and others confirmed that ROCKs inhibitors attenuated the symptoms and progression of experimental models of the abovementioned neurodegenerative diseases by inhibiting neuroinflammation,regulating immune imbalance,repairing the blood-brain barrier,and promoting nerve repair and myelin regeneration.Fasudil,the first ROCKs inhibitor to be used clinically,has a good therapeutic effect on neurodegenerative diseases.Fasudil increases the activity of neural stem cells and mesenchymal stem cells,thus optimizing cell therapy.This review will systematically describe,for the first time,the effects of abnormal activation of ROCKs on T cells,B cells,microglia,astrocytes,oligodendrocytes,and pericytes in neurodegenerative diseases of the central nervous system,summarize the therapeutic potential of fasudil in several experimental models of neurodegenerative diseases,and clarify the possible cellular and molecular mechanisms of ROCKs inhibition.This review also proposes that fasudil is a novel potential treatment,especially in combination with cell-based therapy.Findings from this review add support for further investigation of ROCKs and its inhibitor fasudil for the treatment of neurodegenerative diseases.
文献关键词:
作者姓名:
Qing Wang;Li-Juan Song;Zhi-Bin Ding;Zhi Chai;Jie-Zhong Yu;Bao-Guo Xiao;Cun-Gen Ma
作者机构:
Research Center of Neurobiology,The Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple Sclerosis of State Administration of Traditional Chinese Medicine,Shanxi University of Chinese Medicine,Jinzhong,Shanxi Province,China;Department of Physiology,Shanxi Medical University,Taiyuan,Shanxi Province,China;Institute of Brain Science,Shanxi Key Laboratory of Inflammatory Neurodegenerative Diseases,Shanxi Datong University,Datong,Shanxi Province,China;Department of Neurology,Datong Fifth People's Hospital,Datong,Shanxi Province,China;Institute of Neurology,Huashan Hospital,Institutes of Brain Science and State Key Laboratory of Medical Neurobiology,Fudan University,Shanghai,China
引用格式:
[1]Qing Wang;Li-Juan Song;Zhi-Bin Ding;Zhi Chai;Jie-Zhong Yu;Bao-Guo Xiao;Cun-Gen Ma-.Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases)[J].中国神经再生研究(英文版),2022(12):2623-2631
A类:
fasudil,ROCKs
B类:
Advantages,Rho,associated,kinases,their,treatment,neurodegenerative,diseases,Ras,homolog,belong,serine,threonine,family,which,plays,pivotal,role,regulating,damage,survival,axon,guidance,regeneration,neurons,are,also,involved,biological,effects,immune,cells,glial,well,development,disorders,such,Alzheimer,Parkinson,multiple,sclerosis,Previous,studies,by,others,confirmed,that,inhibitors,attenuated,symptoms,progression,experimental,models,abovementioned,inhibiting,neuroinflammation,imbalance,repairing,blood,brain,barrier,promoting,nerve,myelin,Fasudil,first,used,clinically,has,good,therapeutic,increases,activity,neural,mesenchymal,thus,optimizing,therapy,This,review,will,systematically,describe,abnormal,activation,microglia,astrocytes,oligodendrocytes,pericytes,central,nervous,summarize,potential,several,clarify,possible,cellular,molecular,mechanisms,inhibition,proposes,novel,especially,combination,Findings,from,this,add,support,further,investigation,its
AB值:
0.533585
相似文献
Structural basis of the activation of metabotropic glutamate receptor 3
Wei Fang;Fan Yang;Chanjuan Xu;Shenglong Ling;Li Lin;Yingxin Zhou;Wenjing Sun;Xiaomei Wang;Peng Liu;Philippe Rondard;Pan Shi;Jean-Philippe Pin;Changlin Tian;Jianfeng Liu-The First Affiliated Hospital of USTC,School of Life Sciences,Division of Life Sciences and Medicine,Joint Center for Biological Analytical Chemistry,Anhui Engineering Laboratory of Peptide Drug,Anhui Laboratory of Advanced Photonic Science and Technology,University of Science and Technology of China,Hefei,Anhui,China;Key Laboratory of Molecular Biophysics of MOE,International Research Center for Sensory Biology and Technology of MOST,College of Life Science and Technology,Huazhong University of Science and Technology(HUST),Wuhan,Hubei,China;Bioland Laboratory,Guangzhou Regenerative Medicine and Health Guangdong Laboratory,Guangzhou,Guangdong,China;Institut de Génomique Fonctionnelle(IGF),Université de Montpellier,CNRS,INSERM,Montpellier,France
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Corynoxine B derivative CB6 prevents Parkinsonian toxicity in mice by inducing PIK3C3 complex-dependent autophagy
Zhou Zhu;Liang-feng Liu;Cheng-fu Su;Jia Liu;Benjamin Chun-Kit Tong;Ashok lyaswamy;Senthilkumar Krishnamoorthi;Sravan Gopalkrishnashetty Sreenivasmurthy;Xin-jie Guan;Yu-xuan Kan;Wen-jian Xie;Chen-liang Zhao;King-ho Cheung;Jia-hong Lu;Jie-qiong Tan;Hong-jie Zhang;Ju-xian Song;Min Li-Mr.&Mrs.Ko Chi-Ming Centre for Parkinson's Disease Research,School of Chinese Medicine,Hong Kong Baptist University,Hong Kong,SAR,China;School of Chinese Medicine,Hong Kong Baptist University,Hong Kong,SAR,China;institute for Research and Continuing Education,Hong Kong Baptist University,Shenzhen 518057,China;Limin Pharmaceutical Factory,Livzon Group Limited,Shaoguan 512028,China;State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau,Macau,SAR,China;Center for Medical Genetics and Hunan Key Laboratory of Animal Model for Human Diseases,School of Life Sciences,Central South University,Changsha 410078,China;Medical College of Acupuncture-Moxibustion and Rehabilitation,Guangzhou University of Chinese Medicine,Guangzhou 510006,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。